β-lactam-aminoglycoside
Showing 1 - 25 of 1,208
/ Pharmacodynamic Data and Interest Individualized Therapeutic
Active, not recruiting
- Severe Infection
- Drug Monitoring
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Mar 30, 2022
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Beta-lactam antibiotic, Aminoglycoside)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis Pulmonary Exacerbation
- Beta-lactam antibiotic
- Aminoglycoside
- (no location specified)
Sep 16, 2022
Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated
Active, not recruiting
- Streptococcal Sepsis
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center (primary center co
Nov 8, 2023
Sepsis Trial (prolonged intravenous infusion of ß-lactams Antibiotics)
Not yet recruiting
- Sepsis
- prolonged intravenous infusion of β-lactams Antibiotics
- (no location specified)
Aug 22, 2021
Community-acquired Pneumonia, Sepsis, Inflammatory Response Trial in Greece (Tablets, Clarithromycin 500mg)
Active, not recruiting
- Community-acquired Pneumonia
- +5 more
- Tablets
- Clarithromycin 500mg
-
Alexandroupolis, Greece
- +25 more
Jan 11, 2023
Infections Trial in Shanghai (SZEY-2108 for injetion, Placebo)
Recruiting
- Infections
- SZEY-2108 for injetion
- Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Sep 24, 2023
Febrile Neutropenia Trial in Hospitalet de Llobregat (Piperacillin-Tazobactam 4 g-0.5 g, Cefepime 2000 mg, Meropenem 1000 mg)
Unknown status
- Febrile Neutropenia
- Piperacillin-Tazobactam 4 g-0.5 g
- +2 more
-
Hospitalet de Llobregat, Barcelona, SpainHospital Duran i Reynals
Feb 11, 2021
Intensive Care Unit Syndrome Trial in Lille (pharmacokinetic device)
Unknown status
- Intensive Care Unit Syndrome
- pharmacokinetic device
-
Lille, FranceHôpital Roger Salengro, CHU
Aug 19, 2020
Sepsis Trial in France (continuous pivotal ßL-AB, intermittent pivotal ßL-AB, AG infusion most 1 dose)
Not yet recruiting
- Sepsis
- continuous pivotal βL-AB
- +3 more
-
Amiens, France
- +23 more
Feb 1, 2023
Machine Learning Model for Beta-Lactam Drugs Related Acute
Active, not recruiting
- Acute Kidney Injury
- Beta-Lactam Antibiotic Toxicity (Diagnosis)
- Beta-Lactam Drugs
-
Jinan, Shandong, ChinaXiao Li，MD
Sep 8, 2022
Extended Spectrum Beta Lactamase Producing Organisms In Urinary
Not yet recruiting
- Urinary Tract Infections
- (no location specified)
Nov 18, 2021
Phenotypic and Genotypic Variations of Enterococcus Spp
Not yet recruiting
- Isolation of Enterococci From Samples
- +5 more
- Culture
- +7 more
- (no location specified)
Mar 1, 2023
Urinary Tract Infections, Urological System Complication of Procedure Trial (mannitol-enhanced aminoglycoside, Ceftriaxon,
Not yet recruiting
- Urinary Tract Infections
- Urological System Complication of Procedure
- mannitol-enhanced aminoglycoside
- +2 more
- (no location specified)
Mar 7, 2023
Pneumonia Trial in Machakos (Benzyl penicillin, Gentamicin Sulfate, Ceftriaxone)
Recruiting
- Pneumonia
- Benzyl penicillin
- +6 more
-
Machakos, KenyaMachakos Level 5 Hospital
Nov 1, 2022
Single-stage Exchange of ProstheTic Infections inCenter of
Unknown status
- Infected of Hip or Kneeprosthesis
-
Strasbourg, FranceService de Chirurgie Orthopédique Septique
Oct 10, 2019
Enterobacteria Infections Trial in Paris, Bobigny, Corbeil-Essonnes (Control (Patients colonized rectally with ESBL-producing
Recruiting
- Enterobacteria Infections
- Control (Patients colonized rectally with ESBL-producing enterobacteria without antibiotic pressure)
- Case (Patients colonized rectally with ESBL-producing enterobacteriaceae, with antibiotic pressure)
-
Paris, Groupe Hospitalier Paris Saint-Joseph, France
- +3 more
Aug 17, 2022
Bacterial Meningitis Trial in Luanda (Infusion with paracetamol, Bolus without paracetamol)
Completed
- Bacterial Meningitis
- Infusion with paracetamol
- Bolus without paracetamol
-
Luanda, AngolaHospital Pediatrico David Bernardino
Sep 22, 2019
Beta-lactam Target Non-attainment Risk Score in Adult ICU
Not yet recruiting
- Infection, Bacterial
- +4 more
- (no location specified)
Sep 13, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
Lower Extremity Fracture Trial in Dallas (Cephalosporin 1St Generation, Aminoglycosides)
Suspended
- Lower Extremity Fracture
- Cephalosporin 1St Generation
- Aminoglycosides
-
Dallas, TexasMethodist Health System
Mar 1, 2022
Cystic Fibrosis, Pneumonia, Bacterial Trial in United States (Imipenem/Cilastatin/Relebactam)
Recruiting
- Cystic Fibrosis
- Pneumonia, Bacterial
-
Hartford, Connecticut
- +6 more
Jan 3, 2023
Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia
Not yet recruiting
- Sickle Cell Disease, Beta Thalassemia Intermedia
- RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
- (no location specified)
May 30, 2023
Cross-allergies Between Cefazolin and Amoxicillin With Skin
Recruiting
- Allergic Reaction
- Beta Lactam Adverse Reaction
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Nov 7, 2022